HCV - Liver Cirrhosis

Pegylated Interferon plus Ribavirin for Patients with HCV-related Liver Cirrhosis - 3/11/08

Non-Invasive Ways to Assess Liver Disease: Studies Test Alternatives to Liver Biopsy - 2/05/08

Human Genetic Variation May Protect Against HCV-related Liver Disease Progression - 1/04/08

Non-invasive FibroTest and FibroScan Predict Liver Cirrhosis Better than Earlier Stages of Fibrosis in Hepatitis C Patients - 12/11/07

CD4 Cell Count Preferred over CD4 Cell Percentage for Monitoring HIV Disease Progression in People with Cirrhosis   - 8/21/07

Treatment with Pegasys Plus Ribavirin in Genotype 2/3 Chronic Hepatitis C Patients with Liver Cirrhosis  - 5/22/07

Transient Elastography as a Non-invasive Method for Predicting Portal Hypertension in Patients with Hepatitis C-related Cirrhosis  - 5/18/07

Racial Disparities in Treatment of Patients with Cirrhosis and Complications of Portal Hypertension  - 5/15/07

Sustained Response to Interferon Monotherapy Reduces Rates of Liver Cancer and Death in Patients with HCV-related Cirrhosis  - 3/27/07

Impact of Cirrhosis on CD4 Cell Counts in HIV Negative Individuals Has Implications for HIV-HCV and HIV-HBV Coinfected Patients 1/29/07

Treatment of Hepatitis C in Patients with Advanced Fibrosis or Cirrhosis  12/08/06

Treatment Response in Cirrhotic Hepatitis C Patients with Portal Hypertension  11/21/06

Contributions of Hepatitis B and C to Cirrhosis and Primary Liver Cancer Worldwide   9/12/06

Diabetes is Associated with Hepatic Encephalopathy in Patients with HCV-Related Cirrhosis- 8/18/06

HCC and Non-Liver Cancers in People with Cirrhosis - 6/23/06

Natural History of Liver Cirrhosis Due to Hepatitis C - 6/16/06